American Portfolios Advisors’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$15.4K Buy
848
+196
+30% +$8.49K ﹤0.01% 2314
2022
Q2
$33.5K Hold
652
﹤0.01% 1985
2022
Q1
$48K Buy
652
+56
+9% +$4.99K ﹤0.01% 1899
2021
Q4
$85.3K Sell
596
-14
-2% -$2.41K ﹤0.01% 1588
2021
Q3
$126K Buy
610
+418
+218% +$92.1K ﹤0.01% 1346
2021
Q2
$40.8K Sell
192
-34
-15% -$6.23K ﹤0.01% 1831
2021
Q1
$41K Sell
226
-3,092
-93% -$616K ﹤0.01% 1694
2020
Q4
$370K Buy
3,318
+2,693
+431% +$286K 0.02% 664
2020
Q3
$67.7K Sell
625
-307
-33% -$37.4K ﹤0.01% 1218
2020
Q2
$77.7K Buy
932
+200
+27% +$7.65K 0.01% 1101
2020
Q1
$9.94K Buy
732
+582
+388% +$4.92K ﹤0.01% 1813
2019
Q4
$597 Hold
150
﹤0.01% 2735
2019
Q3
$753 Hold
150
﹤0.01% 2679
2019
Q2
$879 Hold
150
﹤0.01% 2600
2019
Q1
$1.65K Sell
150
-1,000
-87% -$31.6K ﹤0.01% 2412
2018
Q4
$42.3K Buy
1,150
+1,000
+667% +$38.8K 0.01% 1087
2018
Q3
$5.64K Hold
150
﹤0.01% 1964
2018
Q2
$4.02K Sell
150
-500
-77% -$16.9K ﹤0.01% 2051
2018
Q1
$27.3K Buy
650
+500
+333% +$20.1K ﹤0.01% 1266
2017
Q4
$3.72K Buy
+150
New +$3.66K ﹤0.01% 1929

Other funds holding NVAX

American Portfolios Advisors's NVAX Position: Q3 2022 in Review

American Portfolios Advisors increased its Novavax (NVAX) stake by 30% in Q3 2022, buying an estimated $8.49K and bringing the position to 848 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2314.

American Portfolios Advisors first reported a position in NVAX in Q4 2017 and has held it in 20 quarters since. The position peaked at $370K in Q4 2020. 254 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • American Portfolios Advisors held 848 shares of Novavax worth $15.4K as of Q3 2022.
  • American Portfolios Advisors bought 196 Novavax shares in Q3 2022, an estimated $8.49K.
  • Novavax made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2314 holding.
  • American Portfolios Advisors first reported a position in Novavax in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's Novavax position peaked at $370K in Q4 2020.
  • 254 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.